Comprehensive guide to how 15 common medical conditions affect life insurance premiums, underwriting, and coverage in Australia. Includes real cost data, insurer comparisons, and approval strategies.
Complete guide to life insurance in Australia covering types, costs, and how to apply
Life insurance with diabetes: how Type 1 and Type 2 affect coverage, premiums, and application strategies
Mental health and life insurance: how insurers assess depression, anxiety, and other conditions
General Advice Only
Insure Me For Life is Authorised Representative Number 1244847 of Consilium Advice Australia Pty Ltd, Australian Financial Services Licence 246623.
Medical Disclaimer: This article discusses how various medical conditions may affect insurance applications. It does not constitute medical advice. For medical guidance about managing any health condition, consult your treating specialist or GP.
Most medical conditions don't automatically disqualify you from life insurance in Australia. What matters is how well your condition is managed, whether complications have developed, and which insurer assesses your application.
This guide examines 15 common medical conditions and their impact on life insurance. We've analysed Product Disclosure Statements (PDS) from major Australian insurers and referenced cost data from Zurich's Cost of Care Volume 2 research.
You'll learn:
Important context: This is general information based on industry practices. Individual circumstances vary significantly. Always disclose your complete medical history to insurers and seek specific advice from licensed financial advisers.
This guide describes what insurers assess. It does not predict what any insurer will decide, because appetite for the same condition differs materially between them and individual factors move outcomes more than a generic table can capture. A pre-assessment through a broker is the only reliable way to gauge insurer appetite for your specific situation before submitting a formal application.
Before examining specific conditions, it's essential to understand how insurers assess medical risk.
Australian life insurers use a three-tier approach for medical conditions:
Tier 1: Automatic acceptance (standard rates)
Tier 2: Conditional acceptance (premium loading)
Tier 3: Decline or postponement
When you disclose a medical condition, underwriters evaluate five key factors:
1. Severity and stage
2. Treatment and control
3. Time since diagnosis
4. Complications and co-morbidities
5. Lifestyle factors
Depending on your condition, insurers may request:
Tip: Gather this documentation before applying. It speeds up the underwriting process and shows organisation, which underwriters notice.
Cardiovascular conditions are heavily scrutinised because they directly correlate with mortality risk. Mortality risk is the primary factor life insurers assess.
Prevalence: A common condition among Australian adults, with prevalence rising sharply with age (Source: AIHW).
Underwriting criteria: Insurers will assess:
The exact loading depends on the insurer, readings, medication history, and evidence of organ damage. TAL's PDS (Section 9, Definitions) and equivalent underwriting guidelines from other panel insurers drive these assessments. A pre-assessment through a broker is the most reliable way to gauge the loading for your profile before a formal application.
Approval strategy:
The assessment turns on the severity of the original event, treatment received, time elapsed, and ongoing cardiac risk-factor control. Insurer appetite varies significantly.
Underwriting criteria: Insurers focus on:
Critical factor: terminal illness definition: If you're approved with a history of heart attack, pay close attention to the terminal illness benefit period:
A 24-month definition is significantly more valuable if you experience subsequent cardiac events. Many cardiac conditions have prognoses in the 12 to 24 month range.
Approval strategy:
Underwriting criteria:
Approval strategy: High cholesterol is assessed alongside your other cardiovascular risk factors rather than in isolation. If this is your only condition:
Prevalence:
Lifetime Cost:
What drives the assessment:
Insurers separate Type 1 from Type 2 and then weigh HbA1c control and trend, time since diagnosis, whether complications (retinopathy, neuropathy, nephropathy) have developed, how the condition is monitored and managed, and smoking status. The outcome depends heavily on the individual insurer's appetite for diabetes. Some panel insurers are materially more accepting than others. Specific HbA1c thresholds and loading ranges are not published consistently. Your broker can pre-approach the panel to establish which insurers will look at your profile.
Underwriting criteria: Insurers assess diabetes more thoroughly than almost any other condition:
Key statistics from Zurich research:
Where insurers differ: Diabetes is one of the conditions where panel appetite diverges most. Insurers differ on the HbA1c range they will look at, on whether they assess Type 1 at all, on how much weight they give to modern management technology such as pumps and continuous glucose monitors, and on how they treat any complication that has already developed. This is why the same profile can be assessed very differently across the panel.
Approval strategy:
Optimise control before applying (6 to 12 months):
Eliminate or stabilise complications:
Gather supporting evidence:
Timing matters:
Consider pre-assessment screening:
Why this matters: Two applicants with the same diabetes profile (say HbA1c 6.8%, stable on Metformin, no complications, BMI 28, non-smoker) can be assessed very differently depending on which insurers see the file, because each insurer applies its own internal diabetes policy. That variation is why a pre-assessment through a broker who can pre-approach the panel is particularly valuable for this condition.
For a focused walkthrough of diabetes underwriting (HbA1c thresholds, complications screening, insulin vs oral therapy, and how panel insurers treat Type 1 differently to Type 2), see our dedicated post: Life Insurance with Diabetes: Australian Buyer's Guide.
Prevalence: A common condition among Australian adults, with overweight and obese categories together representing the majority of the adult population (Source: AIHW).
Underwriting criteria:
Important note: Obesity is rarely the sole reason for premium loading. The associated conditions (diabetes, hypertension, sleep apnea, cardiovascular disease) drive increases.
Approval strategy:
Mental health conditions are increasingly recognised and accepted by Australian life insurers, though underwriting remains careful and individualised.
Prevalence:
Cost Data:
Underwriting criteria:
Key statistics from Zurich research:
These relapse rates are why insurers place so much weight on how long you have been stable since your last episode or treatment change.
A pre-assessment through a broker is the only reliable way to gauge insurer appetite for your specific situation before submitting a formal application.
Approval strategy:
Timing is everything:
Demonstrate stability:
Consider Income Protection priority:
Disclosure is critical:
For a deeper walkthrough of how depression, anxiety, bipolar disorder, PTSD, and other mental health conditions affect Life, TPD, Trauma, and (especially) Income Protection underwriting, see our dedicated post: Mental Health and Life Insurance in Australia: What You Need to Know. This includes stability benchmarks, IP-specific exclusions, and crisis support resources.
Prevalence: Males 2x more likely than females (Zurich Cost of Care Volume 2, Section 11.3)
Underwriting criteria:
Approval strategy:
Neurological conditions are expensive to treat and have significant mortality implications. Underwriting is particularly careful.
Prevalence: 1 in 330 by age 80 (Zurich Cost of Care Volume 2, Section 6.4)
Annual Cost: $47,920 per year (Zurich Cost of Care Volume 2)
What drives the assessment:
Insurers weigh the form of MS (relapsing-remitting versus progressive), relapse frequency and how long since the last one, current disability and functional capacity, and response to disease-modifying therapy. MS is one of the conditions where insurer appetite varies most, so a pre-assessment before any formal application matters here more than usual.
Why insurers are cautious: MS statistics from Zurich research show why underwriters examine this condition so closely:
Approval strategy: If you have MS:
Prevalence: 1 in 300 (Zurich Cost of Care Volume 2, Section 6.5)
Lifetime Cost: $201,340 (Zurich Cost of Care Volume 2)
What drives the assessment: Average survival time after diagnosis is 2.5 years (Zurich Cost of Care Volume 2). Mortality risk over the term of a policy is the primary factor life insurers assess, so a diagnosis with that prognosis is the dominant consideration in any application.
If you already hold cover, or if you are looking at this after a diagnosis, the more relevant routes are usually:
Prevalence: Numbers increased 37% over five years (Zurich Cost of Care Volume 2, Section 6.3)
Lifetime Cost: $190,000 (Zurich Cost of Care Volume 2)
What drives the assessment:
Insurers weigh the stage of the disease, the degree of symptom and mobility impact, response to medication, time since diagnosis, and maintained work capacity.
Key statistics:
Approval strategy: As with MS, insurer appetite varies and a pre-assessment is worth doing first. Best approach:
Musculoskeletal conditions are less likely to affect Life Insurance premiums significantly (they don't typically shorten lifespan). They heavily impact Income Protection and TPD coverage.
Prevalence: 1 in 6 Australians (Zurich Cost of Care Volume 2, Section 9.1)
Annual Cost: $8,988 ($749/month) (Zurich Cost of Care Volume 2)
What drives the assessment:
Insurers weigh whether the episode has resolved or is ongoing, how it is being managed, the degree of functional limitation, imaging and surgical history, and your occupation. Because the Income Protection and TPD question is work capacity rather than mortality, the same back history can be assessed quite differently across cover types.
Key statistics:
Approval strategy:
Prevalence: 1 in 66 men, 1 in 43 women (Zurich Cost of Care Volume 2, Section 9.4)
Annual Cost: $14,170 median (Zurich Cost of Care Volume 2)
What drives the assessment:
Insurers weigh current disease activity (inflammatory markers), the extent of joint damage, the treatment regimen and response to it, functional capacity, and the associated cardiovascular risk.
Critical statistic: "The risk of heart attack increases 60% one year after being diagnosed with RA" (Zurich Cost of Care Volume 2, Section 9.4)
That cardiovascular risk is why RA is assessed for Life cover at all, and not treated purely as an Income Protection question.
Approval strategy:
Prevalence: 1 in 5 Australians over age 45 (Zurich Cost of Care Volume 2, Section 9.2)
What drives the assessment: The joints involved, the degree of functional limitation, treatment and any joint replacement history, and your occupation.
Osteoarthritis does not generally affect life expectancy, which is the question Life cover is underwritten on. It bears far more on Income Protection and TPD, where the question is work capacity, and more again where the occupation is manual.
Cancer history is evaluated based on type, stage, treatment, and time since remission.
Time since remission is the single biggest factor. Insurers count from the end of treatment or from confirmed remission, and how much time they want before they will look at an application differs by cancer type, stage and grade as well as by insurer.
Cancer type matters as much as elapsed time. Insurers assess the mortality profile of the specific cancer, so an early-stage melanoma or thyroid cancer is a different conversation from a pancreatic, lung or brain cancer, and the intermediate group (breast, prostate, colorectal) turns heavily on stage and grade.
Factors assessed:
Real examples from trauma insurance: Across the panel, where an insurer's current PDS states a headline count, retail trauma cover commonly spans roughly 34 to 47 full-benefit conditions, including a range of cancers; several insurers list covered events by category without a single headline number (per the Trauma Insurance Conditions Explained corpus comparison and individual insurer PDS documents). Coverage definitions matter:
Approval strategy after cancer:
For a deeper walkthrough of cancer-specific underwriting, see our dedicated post: Life Insurance After Cancer in Australia: What to Expect. This includes how breast, prostate, melanoma, and bowel cancer are assessed differently, what oncology reports insurers expect, and how time-in-remission interacts with cancer type and grade.
Prevalence: 2 million Australians (Zurich Cost of Care Volume 2, Section 8.1)
Annual Cost: $41,748 for those with kidney failure (Zurich Cost of Care Volume 2)
What drives the assessment:
Insurers weigh the CKD stage, whether kidney function has been stable or declining, the underlying cause (diabetes and hypertension are the common ones and are assessed alongside), whether dialysis is involved, and the associated cardiovascular risk.
Key statistics:
Approval strategy:
Prevalence: >1 in 3 vision impairment by age 85 (Zurich Cost of Care Volume 2, Section 10.1)
Annual Cost: $6,595 (Zurich Cost of Care Volume 2)
What drives the assessment:
Vision corrected by glasses or contact lenses is not a disclosure that moves an assessment. Beyond that, insurers weigh the degree and cause of the vision loss, whether it is stable or progressive, any underlying condition driving it (diabetic retinopathy, for instance, is assessed as diabetes), and the effect on work capacity.
Important note: "Living with vision impairment does not mean inability to work. 15% of Vision Australia employees are blind or have low vision" (Zurich Cost of Care Volume 2, Section 10.1)
This statistic shows that vision loss affects TPD and Income Protection more than Life Insurance.
Traditional life insurance underwriting happens after application submission. If you're declined, that decline appears on your record and affects future applications.
The pre-assessment approach (Stage 3.5) inverts this process:
This approach is particularly valuable if you have:
Our medical screening process identifies potential underwriting issues before formal submission, helping avoid declined applications on your record. Free assessment available.
Start Pre-AssessmentTwo insurers looking at the same file can reach very different conclusions, because each applies its own internal underwriting policy. Take a 45-year-old with Type 2 diabetes (HbA1c 7.2%, on Metformin, no complications). Between panel insurers, the things that differ are:
We do not publish predicted decisions insurer by insurer. Those depend on the whole file and on appetite that moves over time, so a table of them would suggest a precision that is not there.
Key takeaway: Comparing multiple insurers isn't just about price. It's about finding an insurer whose underwriting philosophy fits your health profile.
This is a factor reference, not an outcome table. It sets out what underwriters look at for each condition. What any particular insurer then decides depends on the whole file and on that insurer's own appetite, which is what a pre-assessment establishes.
| Feature | What underwriters weigh |
|---|---|
| High Blood Pressure (controlled) | Readings across the past 6 months, medication and dosage, evidence of end-organ damage |
| High Cholesterol (controlled) | Total cholesterol and LDL, medication compliance, other cardiovascular risk factors |
| Type 2 Diabetes (well-controlled) | HbA1c level and trend, complications screening, time since diagnosis, BMI, smoking status |
| Type 1 Diabetes | HbA1c control, how the condition is monitored and managed, complications screening |
| Depression/Anxiety (stable 12+ months) | Episode history, time since the last episode, current treatment, functional capacity |
| Heart Attack (5+ years ago, stable) | Time since the event, severity and treatment received, cardiac function, risk-factor control |
| Cancer (5+ years remission) | Cancer type, stage and grade, time in remission, surveillance scans and markers |
| Multiple Sclerosis | Relapsing-remitting or progressive, relapse frequency, current disability, response to therapy |
| Rheumatoid Arthritis (controlled) | Disease activity markers, extent of joint damage, treatment response, cardiovascular risk |
| Back Pain (chronic) | Whether the episode has resolved, functional limitation, imaging and surgical history, occupation |
| Obesity (BMI 35) | Current BMI and weight trend, associated conditions, surgical history |
| Chronic Kidney Disease (Stage 3) | CKD stage, whether function is stable or declining, underlying cause, cardiovascular risk |
| Vision Loss (partial) | Degree and cause of the loss, whether it is stable or progressive, effect on work capacity |
A factor reference only. It describes what insurers assess, not what any insurer will decide. Individual circumstances and insurer appetite both vary materially.
Insurers assess your current control, not your diagnosis alone, so 6 to 12 months of documented management gives an underwriter far more to work with than a file opened during active treatment.
Action steps:
Eliminate factors that compound medical condition risk:
Proactively compile documentation before applying:
Why this matters: Underwriters view organised, compliant applicants more favourably than those who provide minimal information.
Best times to apply:
Worst times to apply:
Anonymous pre-submission to insurers (Stage 3.5 approach):
The same health profile can be priced quite differently between insurers. What matters:
Strategy: Work with a broker who can approach multiple insurers and identify the most suitable match.
Don't just compare price. Compare definitions:
A 15% higher premium for a 24-month terminal illness definition may be worth it if you have cardiovascular disease risk.
Buying Life + TPD together often saves 10 to 15% compared to separate policies. Additional benefits:
If declined or facing prohibitive loadings:
Strategy: Use group insurance as baseline coverage while improving health to reapply for an individual policy in 12 to 24 months.
Critical warning: Non-disclosure is the #1 reason for claim denial. Always disclose:
Why: Insurers access MBS (Medicare Benefits Schedule) records when processing claims. Undisclosed GP visits or prescriptions will be discovered, resulting in claim denial and forfeited premiums.
Better approach: Disclose fully, work with a broker to present information in best light, and emphasise positive factors.
Consider working with a specialist insurance broker (not just a comparison site) if you have:
Complex medical history:
Previous declined applications:
High-value coverage needs:
Pre-existing condition expertise needed:
A specialist broker can:
We work with complex medical histories daily. Free consultation to assess your insurability and identify suitable insurers.
Book Free ConsultationThis guide is a broad overview. For condition-specific underwriting detail, HbA1c thresholds, oncology timelines, mental-health stability benchmarks, IP-specific exclusion patterns, and panel-by-panel appetite differences, see the dedicated posts below:
The brokerage works across 9 panel insurers (AIA, Zurich, TAL, OnePath, ClearView, NEOS, Encompass, Acenda, Futura). Each insurer has a distinct underwriting personality. What looks like a decline at one is often a moderate loading at another. The condition-specific posts above explain where those differences show up.
Yes. Australian insurance law requires full disclosure of all material facts, which includes:
"Resolved" doesn't mean "no longer relevant." Insurers assess the condition's history, not just current status. For example, depression that was treated successfully 3 years ago should still be disclosed, but will likely receive minimal or no loading given the time elapsed and successful treatment.
Consequence of non-disclosure: Claim denial, policy cancellation, forfeited premiums.
For existing policies:
Exception: If you develop complications and apply for new coverage or increase existing coverage, the new application will be underwritten based on your current health.
Strategy: Once you have coverage, maintain it even if health deteriorates. Your locked-in premium won't increase due to health changes (only age on stepped premiums).
Strategic considerations:
Apply before testing if:
Wait until after testing if:
Important: You must disclose scheduled tests during application. Insurers will postpone decision until results are available. Don't try to "beat" underwriting by applying before scheduled tests - this is considered non-disclosure.
Yes, but you must disclose the previous decline. Best approach:
Typical waiting period before reapplication: 12-24 months with demonstrated improvement.
No. Each person's life insurance premiums are based on their individual health, age, gender, and occupation. Your medical condition doesn't affect your partner's rates.
Exception: If buying "joint life" cover (single policy covering two people), both people's health affects the premium. Joint policies are rare in Australia - most couples have separate policies.
Trauma insurance underwriting is generally stricter than life insurance because trauma events are more common than death. Pre-existing conditions may be excluded.
What drives the assessment: whether your condition is itself one of the insured trauma events, whether it materially raises the risk of others on the covered-conditions list, and how closely the two are linked. An exclusion, where one is applied, is usually written around the condition and the events medically connected to it. With Type 2 diabetes, for example, the events an insurer would look at are the cardiovascular and renal ones rather than the covered list as a whole.
Because trauma definitions are policy wording rather than general practice, what any given insurer will do here is best established by pre-assessment before a formal application.
General guidelines:
Why wait: The period right after diagnosis is unstable. Treatment is being adjusted and the prognosis is not yet clear, so there is little for an underwriter to assess. After 6 to 12 months you can show a stable, documented picture instead.
Yes, often dramatically. Smoking compounds the underwriting impact of nearly every other medical condition. This is especially true for cardiovascular disease, diabetes, respiratory conditions, and cancer history. Across the 9-insurer panel, the tobacco-free benchmark is uniform: 12 months without any nicotine product (cigarettes, vapes, nicotine patches, chewing tobacco) qualifies an applicant for non-smoker rates. There is no graded scale.
Practical implication: If you have a chronic condition AND you smoke, the loading effect is multiplicative, not additive. A moderate diabetes loading plus a smoker loading typically compounds to a combined rate materially higher than either loading on its own. Quitting nicotine for 12 months before applying is one of the highest-leverage actions an applicant with a pre-existing condition can take.
Autoimmune and inflammatory conditions (rheumatoid arthritis, lupus, Crohn's disease, ulcerative colitis, multiple sclerosis, ankylosing spondylitis) are underwritten on the same five factors as other conditions (severity, control, time since diagnosis, complications, lifestyle). Underwriters apply extra emphasis on:
Because autoimmune conditions vary enormously (mild psoriasis vs severe lupus with kidney involvement), insurer appetite is highly individual. Pre-assessment is particularly valuable here. See the broader autoimmune health-condition hub for category-level cost and prevalence data.
Most medical conditions don't automatically disqualify you from life insurance in Australia. What matters is how well your condition is managed, whether complications have developed, and which insurer you apply to.
Key takeaways from this comprehensive analysis:
Control matters more than diagnosis: an underwriter assesses how the condition is being managed and whether complications have developed, not the diagnosis on its own.
Timing is critical: insurers assess your current control, so applying after 6 to 12 months of stable, documented management puts a very different file in front of them than applying during active treatment.
Insurers vary dramatically: appetite for the same condition differs materially between insurers. Comparing multiple insurers is essential, not optional.
Pre-assessment is how you find out before you commit: a health screening run through a broker before any formal submission is the only reliable way to gauge insurer appetite for your specific situation. APRA data shows advised-channel death claims have a 97.2% acceptance rate compared to 92.9% for non-advised channels (June 2025).
Disclosure is non-negotiable: Non-disclosure is the #1 cause of claim denial. Always provide complete medical history.
Strategic improvements change what you present: weight, nicotine use, and medication compliance are all factors an underwriter weighs, and all three are within your control before you apply.
A medical condition that seems like a barrier to coverage today may be entirely manageable with the right preparation, timing, and insurer selection. Work with a specialist broker, optimise your medical control, and approach the application strategically.
Ready to explore your options? A broker experienced with complex medical histories can identify panel insurers with documented appetite for the relevant pre-existing condition before any formal application. Get a free assessment of your insurability.
Free consultation with a specialist broker. We'll assess your medical history and identify suitable insurers before formal application.
Start Free AssessmentImportant Information
Cost estimates are from Zurich Cost of Care Volume 2 research and represent averages. Your actual costs may vary.
Insurance coverage recommendations are general in nature. This is general advice only and does not take into account your individual circumstances. Speak with a licensed financial adviser to determine appropriate coverage for your situation.
Insure Me For Life | AR 1244847 of Consilium Advice Australia Pty Ltd | AFSL 246623